Developer docs
API playgroundTry for free, no card

Search company profiles

BrightSpec

Full company profile

uuid0000brx

Namestring
BrightSpec
Legal namestring
BrightSpec, Inc.
Websiteurl
brightspec.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

BrightSpec is a privately held life science tools company headquartered in Charlottesville, Virginia, with a second office in Waltham, Massachusetts. The company commercializes Molecular Rotational Resonance (MRR) spectroscopy — the first commercial rotational spectroscopy platform introduced in over 50 years — measuring quantized rotational transitions of gas-phase molecules to produce unique, structure-specific spectral fingerprints. BrightSpec's vertically integrated stack combines quantum chemistry simulation software, rotational spectrometers, data analysis tools, and automation to deliver molecular structure identification and quantitation without chromatography, derivatization, or reference standards.

The product portfolio comprises three instrument tiers — the flagship spectraMRR for structure identification and library building, the isoMRR for routine quantitation and chiral analysis, and the compact nanoMRR for education and research — complemented by SpectrAline Cartridges co-developed with Restek Corporation (a consumable launching commercially in June 2026 under a multi-year supply agreement), Edgar data acquisition and analysis software, and the BrightHub cloud-based spectral simulation portal. Revenue is generated through quote-based, multi-year enterprise contracts on high-value instrumentation, with a recurring consumables tail emerging in 2026. The company sells exclusively through direct enterprise field sales with live instrument demonstrations at trade shows (PittCon, Analytica, AOAC, AAPS, EAS, IFT) and at its Waltham demo facility.

BrightSpec targets three primary verticals — pharmaceutical, chemical, and consumer goods (including flavors, fragrances, food & beverage, and cosmetics) — with a secondary education and research segment served by the nanoMRR. Named enterprise customers include GSK (pharmaceutical development and impurity characterization) and BASF (industrial chemistry), with academic users at Lamar University and the Aromatic Plant Research Center. The company is led by CEO Rick Gordon (appointed October 2025, previously CEO of Halo Labs through its acquisition by Waters Corporation) alongside founders Dr. Justin Neill (CTO) and Dave McDaniel (Chief Software Architect), and is backed by Genoa Ventures and Arboretum Ventures following an $18.4 million Series C in December 2022.

Short descriptiontext

BrightSpec commercializes Molecular Rotational Resonance (MRR) spectroscopy instruments — the first commercial platform of its kind in over 50 years — selling spectraMRR, isoMRR, and nanoMRR systems and SpectrAline consumables via direct enterprise field sales to pharmaceutical, chemical, and consumer goods companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCharlottesville, United States
HQ citystring
Charlottesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rotational spectroscopy instruments, molecular rotational resonance, small molecule analysis, chiral analysis spectroscopy, analytical instrumentation
Industry3 codes
PRIMARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
SECONDARYIMAGAFAE
Process Analytical Instrumentation (Gas analyzers, spectroscopy, pH/ORP, conductivity)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Sensors, Instrumentation & Measurement (Industrial sensing, metrology, test)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Analytical Instrumentation (Life Science Tools)
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1MRR Instrumentation Sales
TypeHardware Sales
Description

BrightSpec generates revenue from the sale of Molecular Rotational Resonance spectroscopy instruments (spectraMRR, isoMRR, nanoMRR), each targeting different analytical needs and price points. The company also sells consumables including SpectrAline Cartridges manufactured by Restek under a multi-year supply agreement.

brightspec.com
2Software and Support Services
TypeSubscription Recurring
Description

Revenue likely includes software licensing, maintenance, and support contracts associated with the Edgar software suite and BrightHub portal used for method development, data acquisition, and spectral analysis.

brightspec.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Pricing details3 tiers
1spectraMRR — High-end platform for structure identification, quantitation, library building, and chiral analysis
ModelOtherBilling cadenceMulti-year contract
Notes

Instrument targeted at pharmaceutical and fine chemical development; quote-based pricing

brightspec.com
2isoMRR — Mid-range platform for quantitation and chiral analysis
ModelOtherBilling cadenceMulti-year contract
Notes

Instrument for routine analytical chemists; quote-based pricing

brightspec.com
3nanoMRR — Entry-level benchtop platform for quantitation
ModelOtherBilling cadenceMulti-year contract
Notes

Compact, cost-effective platform for education and research; quote-based pricing

brightspec.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1spectraMRR
Description

Flagship MRR platform for structure identification, quantitation, library building, and chiral analysis. The first commercial MRR instrument in over 50 years.

brightspec.com
+4 more records
Core offering1 text field

BrightSpec designs, manufactures, and sells Molecular Rotational Resonance (MRR) spectroscopy instruments and supporting consumables and software for direct structural identification and quantitation of small molecules in gas, liquid, and headspace samples. The product line consists of three instrument tiers (spectraMRR flagship, isoMRR routine analyzer, and nanoMRR benchtop), SpectrAline preconcentration cartridges co-developed with Restek, and Edgar/BrightHub software for method development, automated spectral analysis, and library building.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • MRR analysis time reduced by >80% compared to conventional GC workflows (10 minutes vs. over 1 hour for essential oil authenticity testing)
+3 more records
Product overview1 text field

BrightSpec offers a portfolio of Molecular Rotational Resonance (MRR) spectroscopy instruments and software. The product line consists of three instrument tiers: spectraMRR™ (flagship platform for structure identification and library building), isoMRR™ (routine quantitation and chiral analysis), and nanoMRR™ (compact benchtop for education and research). These are complemented by SpectrAline™ Cartridges (co-developed with Restek), and software including Edgar (data acquisition and analysis) and BrightHub (cloud-based spectral simulation and library building). The vertically integrated platform combines quantum simulation, rotational spectrometers, data analysis tools, and automation to deliver rapid, unambiguous structural identification and quantification of small molecules.

Product and service6 records
1spectraMRR
CategoryCore Product (Instrument)
Description

BrightSpec's flagship MRR analytical platform designed for pharmaceutical and fine chemical development. Provides high-resolution structure identification and quantification of small molecules including all forms of structural and spatial isomers, with both liquid and headspace sampling capabilities across a 50-300 AMU mass range. Targeted at pharmaceutical, fine chemical, and advanced analytical labs needing unambiguous structure ID, library building, quantitation, and chiral analysis.

2isoMRR
CategoryCore Product (Instrument)
Description

Routine analytical MRR platform optimized for quantifying volatile organic compounds and chiral analysis. Combines precision with versatility for accurate quantification of complex molecular species including isomers and enantiomers in a single measurement, addressing analytical needs in pharmaceuticals, consumer goods, food and beverage, and chemical manufacturing.

3nanoMRR
CategoryCore Product (Instrument)
Description

Compact benchtop MRR instrument for high-precision small-molecule analysis. Operates at 18-26 GHz for molecules under 150 AMU, requires no carrier gases or consumables, and is designed for education, research, and laboratories needing rapid analysis of common solvents and volatile contaminants.

4SpectrAline Cartridges
CategoryConsumable
Description

High-performance preconcentration column consumable co-developed with Restek Corporation for MRR spectroscopy workflows. Enhances sensitivity, improves sample loading efficiency, and enables analysis of challenging sample matrices.

5Edgar Software
CategorySoftware
Description

User-friendly data acquisition and analysis software for rotational spectroscopy. Provides guided method setup, automated scheduling for high-throughput runs of up to 121 samples, and spectral fitting tools that compare acquired spectra to theoretical calculations to deliver actionable structure ID and quantitation insights.

6BrightHub Portal
CategorySoftware
Description

Cloud-based portal for spectral simulation using quantum chemistry calculations and conformer identification. Supports library building and method development workflows that complement BrightSpec's MRR instruments.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-03-09
Description

BrightSpec and Restek Corporation co-developed SpectrAline Cartridges, a preconcentration column product for Molecular Rotational Resonance (MRR) spectroscopy. Restek manufactures the cartridges under a multi-year supply agreement, and they are delivered as a co-branded component by BrightSpec. The product enhances sensitivity, improves sample loading efficiency, and enables analysis of challenging sample matrices for MRR workflows. Available for order beginning June 2026.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

GSK participated in a BrightSpec-hosted webinar presenting how MRR spectroscopy is applied in drug development, specifically for control strategy development and compliance with FDA and ICHM7 guidelines.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

BASF participated in a BrightSpec-hosted webinar presenting MRR as a powerful analytical technique for industrial chemistry, demonstrating its use as an orthogonal approach in their analytical toolkit.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major analytical instruments manufacturer with deep presence in NMR, FTIR, and mass spectrometry. Bruker is the most direct competitor to the analytical challenges BrightSpec addresses (structure identification, chirality, quantitation), and its installed base and application support network represent the incumbent benchmark MRR must displace in pharma and chemical labs.

TypeBroad incumbent
Description

Global leader in GC-MS, LC-MS, and FTIR for pharmaceutical and chemical analysis. Agilent's GC and GC-MS product lines are the primary incumbent workflows that BrightSpec positions MRR against, particularly for residual solvent analysis and impurity characterization in regulated labs.

TypeBroad incumbent
Description

Largest analytical instruments provider with mass spectrometry, NMR, chromatography, and spectroscopy portfolios. Thermo Fisher is the dominant enterprise supplier to pharma QC and chemical labs and is the most capable player to either build or acquire rotational spectroscopy capability if MRR gains traction.

TypeBroad incumbent
Description

Specialist in LC, GC, and MS for pharma and chemical analysis, and acquirer of Halo Labs (former employer of BrightSpec CEO Rick Gordon) in May 2025. Waters is a natural strategic acquirer or competitor for novel analytical instrument platforms serving regulated QC workflows.

5JEOL Ltd.
TypeBroad incumbent
Description

Manufacturer of NMR and mass spectrometry instruments with a strong foothold in academic and pharmaceutical research. JEOL competes with BrightSpec for structural identification and small-molecule analysis budgets, particularly in academic and government research labs.

TypeEmerging player
Description

Public analytical instrument company specializing in compact mass spectrometry for chemical, biomolecule, and forensic analysis. 908 Devices exemplifies the small-footprint, dedicated-workflow instrument category that BrightSpec's nanoMRR also targets, particularly at the benchtop education/research price point.

TypeEmerging player
Description

Developer of ion mobility spectrometry platforms for small-molecule and biopharmaceutical characterization. MOBILion is a comparable emerging instrument company offering an orthogonal separation technology that addresses similar chirality and isomer differentiation challenges that MRR solves.

TypeBroad incumbent
Description

Major analytical and measuring instruments manufacturer with broad GC-MS, LC-MS, FTIR, and spectroscopy portfolios serving pharmaceutical, chemical, and food/beverage markets. Shimadzu competes for the same analytical lab budgets as BrightSpec across multiple verticals.

TypeBroad incumbent
Description

Provider of analytical instruments including FTIR, GC, and chromatography systems for pharma, food, and environmental testing. PerkinElmer's analytical solutions division serves overlapping use cases (residual solvents, impurity profiling, materials characterization) with established customer relationships.

TypeEmerging player
Description

Compact mass spectrometry specialist serving pharmaceutical and academic labs with benchtop expression CMS and interchim-purification products. Advion is a comparable smaller-scale analytical instrument peer focused on democratizing advanced measurement for routine chemists, similar in go-to-market positioning to BrightSpec's isoMRR.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BrightSpec

Analytical Instrumentation (Life Science Tools)brightspec.com

BrightSpec commercializes Molecular Rotational Resonance (MRR) spectroscopy instruments — the first commercial platform of its kind in over 50 years — selling spectraMRR, isoMRR, and nanoMRR systems and SpectrAline consumables via direct enterprise field sales to pharmaceutical, chemical, and consumer goods companies.

What BrightSpec does

BrightSpec is a privately held life science tools company headquartered in Charlottesville, Virginia, with a second office in Waltham, Massachusetts. The company commercializes Molecular Rotational Resonance (MRR) spectroscopy — the first commercial rotational spectroscopy platform introduced in over 50 years — measuring quantized rotational transitions of gas-phase molecules to produce unique, structure-specific spectral fingerprints. BrightSpec's vertically integrated stack combines quantum chemistry simulation software, rotational spectrometers, data analysis tools, and automation to deliver molecular structure identification and quantitation without chromatography, derivatization, or reference standards.

The product portfolio comprises three instrument tiers — the flagship spectraMRR for structure identification and library building, the isoMRR for routine quantitation and chiral analysis, and the compact nanoMRR for education and research — complemented by SpectrAline Cartridges co-developed with Restek Corporation (a consumable launching commercially in June 2026 under a multi-year supply agreement), Edgar data acquisition and analysis software, and the BrightHub cloud-based spectral simulation portal. Revenue is generated through quote-based, multi-year enterprise contracts on high-value instrumentation, with a recurring consumables tail emerging in 2026. The company sells exclusively through direct enterprise field sales with live instrument demonstrations at trade shows (PittCon, Analytica, AOAC, AAPS, EAS, IFT) and at its Waltham demo facility.

BrightSpec targets three primary verticals — pharmaceutical, chemical, and consumer goods (including flavors, fragrances, food & beverage, and cosmetics) — with a secondary education and research segment served by the nanoMRR. Named enterprise customers include GSK (pharmaceutical development and impurity characterization) and BASF (industrial chemistry), with academic users at Lamar University and the Aromatic Plant Research Center. The company is led by CEO Rick Gordon (appointed October 2025, previously CEO of Halo Labs through its acquisition by Waters Corporation) alongside founders Dr. Justin Neill (CTO) and Dave McDaniel (Chief Software Architect), and is backed by Genoa Ventures and Arboretum Ventures following an $18.4 million Series C in December 2022.

BrightSpec firmographics

Firmographics
Name
BrightSpec
Legal name
BrightSpec, Inc.
Website
https://brightspec.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
BrightSpec commercializes Molecular Rotational Resonance (MRR) spectroscopy instruments — the first commercial platform of its kind in over 50 years — selling spectraMRR, isoMRR, and nanoMRR systems and SpectrAline consumables via direct enterprise field sales to pharmaceutical, chemical, and consumer goods companies.
Ownership category
akta.pro rank

BrightSpec industry classification

Industry
Product category
Analytical Instrumentation (Life Science Tools)
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
SECONDARYIMAGAFAE
Process Analytical Instrumentation (Gas analyzers, spectroscopy, pH/ORP, conductivity)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Sensors, Instrumentation & Measurement (Industrial sensing, metrology, test)

Keywords

  • Rotational spectroscopy instruments
  • Molecular rotational resonance
  • Small molecule analysis
  • Chiral analysis spectroscopy
  • Analytical instrumentation

Where BrightSpec is headquartered

Location

Headquarters

HQ city
Charlottesville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

BrightSpec business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. MRR Instrumentation Sales: BrightSpec generates revenue from the sale of Molecular Rotational Resonance spectroscopy instruments (spectraMRR, isoMRR, nanoMRR), each targeting different analytical needs and price points. The company also sells consumables including SpectrAline Cartridges manufactured by Restek under a multi-year supply agreement.
  2. Software and Support Services: Revenue likely includes software licensing, maintenance, and support contracts associated with the Edgar software suite and BrightHub portal used for method development, data acquisition, and spectral analysis.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractspectraMRR — High-end platform for structure identification, quantitation, library building, and chiral analysis
OtherMulti-year contractisoMRR — Mid-range platform for quantitation and chiral analysis
OtherMulti-year contractnanoMRR — Entry-level benchtop platform for quantitation

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

BrightSpec product offering

Product offering

Core offering

BrightSpec designs, manufactures, and sells Molecular Rotational Resonance (MRR) spectroscopy instruments and supporting consumables and software for direct structural identification and quantitation of small molecules in gas, liquid, and headspace samples. The product line consists of three instrument tiers (spectraMRR flagship, isoMRR routine analyzer, and nanoMRR benchtop), SpectrAline preconcentration cartridges co-developed with Restek, and Edgar/BrightHub software for method development, automated spectral analysis, and library building.

Product overview

BrightSpec offers a portfolio of Molecular Rotational Resonance (MRR) spectroscopy instruments and software. The product line consists of three instrument tiers: spectraMRR™ (flagship platform for structure identification and library building), isoMRR™ (routine quantitation and chiral analysis), and nanoMRR™ (compact benchtop for education and research). These are complemented by SpectrAline™ Cartridges (co-developed with Restek), and software including Edgar (data acquisition and analysis) and BrightHub (cloud-based spectral simulation and library building). The vertically integrated platform combines quantum simulation, rotational spectrometers, data analysis tools, and automation to deliver rapid, unambiguous structural identification and quantification of small molecules.

Differentiator

Problem solved

Functional benefit

Brands

  • spectraMRR: Flagship MRR platform for structure identification, quantitation, library building, and chiral analysis. The first commercial MRR instrument in over 50 years.
  • isoMRR
  • nanoMRR
  • SpectrAline Cartridges
  • Edgar

Products and services

  • spectraMRR BrightSpec's flagship MRR analytical platform designed for pharmaceutical and fine chemical development. Provides high-resolution structure identification and quantification of small molecules including all forms of structural and spatial isomers, with both liquid and headspace sampling capabilities across a 50-300 AMU mass range. Targeted at pharmaceutical, fine chemical, and advanced analytical labs needing unambiguous structure ID, library building, quantitation, and chiral analysis.
  • isoMRR Routine analytical MRR platform optimized for quantifying volatile organic compounds and chiral analysis. Combines precision with versatility for accurate quantification of complex molecular species including isomers and enantiomers in a single measurement, addressing analytical needs in pharmaceuticals, consumer goods, food and beverage, and chemical manufacturing.
  • nanoMRR Compact benchtop MRR instrument for high-precision small-molecule analysis. Operates at 18-26 GHz for molecules under 150 AMU, requires no carrier gases or consumables, and is designed for education, research, and laboratories needing rapid analysis of common solvents and volatile contaminants.
  • SpectrAline Cartridges High-performance preconcentration column consumable co-developed with Restek Corporation for MRR spectroscopy workflows. Enhances sensitivity, improves sample loading efficiency, and enables analysis of challenging sample matrices.
  • Edgar Software User-friendly data acquisition and analysis software for rotational spectroscopy. Provides guided method setup, automated scheduling for high-throughput runs of up to 121 samples, and spectral fitting tools that compare acquired spectra to theoretical calculations to deliver actionable structure ID and quantitation insights.
  • BrightHub Portal Cloud-based portal for spectral simulation using quantum chemistry calculations and conformer identification. Supports library building and method development workflows that complement BrightSpec's MRR instruments.

Quantifiable outcome

  • MRR analysis time reduced by >80% compared to conventional GC workflows (10 minutes vs. over 1 hour for essential oil authenticity testing)
  • +3 more outcomes

Companies that use BrightSpec

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

BrightSpec technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

BrightSpec partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Restek CorporationcoreOEM/ Whitelabel/ Licensing Partner · 9 March 2026BrightSpec and Restek Corporation co-developed SpectrAline Cartridges, a preconcentration column product for Molecular Rotational Resonance (MRR) spectroscopy. Restek manufactures the cartridges under a multi-year supply agreement, and they are delivered as a co-branded component by BrightSpec. The product enhances sensitivity, improves sample loading efficiency, and enables analysis of challenging sample matrices for MRR workflows. Available for order beginning June 2026.
  • GSKminorStrategic or Co-development PartnerGSK participated in a BrightSpec-hosted webinar presenting how MRR spectroscopy is applied in drug development, specifically for control strategy development and compliance with FDA and ICHM7 guidelines.
  • BASFminorStrategic or Co-development PartnerBASF participated in a BrightSpec-hosted webinar presenting MRR as a powerful analytical technique for industrial chemistry, demonstrating its use as an orthogonal approach in their analytical toolkit.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

BrightSpec competitors and assessment

Company assessment

Broad incumbents

  • Bruker Corporation: Major analytical instruments manufacturer with deep presence in NMR, FTIR, and mass spectrometry. Bruker is the most direct competitor to the analytical challenges BrightSpec addresses (structure identification, chirality, quantitation), and its installed base and application support network represent the incumbent benchmark MRR must displace in pharma and chemical labs.
  • Agilent Technologies: Global leader in GC-MS, LC-MS, and FTIR for pharmaceutical and chemical analysis. Agilent's GC and GC-MS product lines are the primary incumbent workflows that BrightSpec positions MRR against, particularly for residual solvent analysis and impurity characterization in regulated labs.
  • Thermo Fisher Scientific: Largest analytical instruments provider with mass spectrometry, NMR, chromatography, and spectroscopy portfolios. Thermo Fisher is the dominant enterprise supplier to pharma QC and chemical labs and is the most capable player to either build or acquire rotational spectroscopy capability if MRR gains traction.
  • Waters Corporation: Specialist in LC, GC, and MS for pharma and chemical analysis, and acquirer of Halo Labs (former employer of BrightSpec CEO Rick Gordon) in May 2025. Waters is a natural strategic acquirer or competitor for novel analytical instrument platforms serving regulated QC workflows.
  • JEOL Ltd. Manufacturer of NMR and mass spectrometry instruments with a strong foothold in academic and pharmaceutical research. JEOL competes with BrightSpec for structural identification and small-molecule analysis budgets, particularly in academic and government research labs.
  • Shimadzu Scientific Instruments: Major analytical and measuring instruments manufacturer with broad GC-MS, LC-MS, FTIR, and spectroscopy portfolios serving pharmaceutical, chemical, and food/beverage markets. Shimadzu competes for the same analytical lab budgets as BrightSpec across multiple verticals.
  • PerkinElmer: Provider of analytical instruments including FTIR, GC, and chromatography systems for pharma, food, and environmental testing. PerkinElmer's analytical solutions division serves overlapping use cases (residual solvents, impurity profiling, materials characterization) with established customer relationships.

Emerging players

  • 908 Devices: Public analytical instrument company specializing in compact mass spectrometry for chemical, biomolecule, and forensic analysis. 908 Devices exemplifies the small-footprint, dedicated-workflow instrument category that BrightSpec's nanoMRR also targets, particularly at the benchtop education/research price point.
  • MOBILion Systems: Developer of ion mobility spectrometry platforms for small-molecule and biopharmaceutical characterization. MOBILion is a comparable emerging instrument company offering an orthogonal separation technology that addresses similar chirality and isomer differentiation challenges that MRR solves.
  • Advion: Compact mass spectrometry specialist serving pharmaceutical and academic labs with benchtop expression CMS and interchim-purification products. Advion is a comparable smaller-scale analytical instrument peer focused on democratizing advanced measurement for routine chemists, similar in go-to-market positioning to BrightSpec's isoMRR.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

BrightSpec social profiles

Digital presence

BrightSpec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BrightSpec leadership team

Management profile

Number of profiles

Profiles11 records

BrightSpec funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BrightSpec M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BrightSpec

What does BrightSpec do?

BrightSpec designs, manufactures, and sells Molecular Rotational Resonance (MRR) spectroscopy instruments and supporting consumables and software for direct structural identification and quantitation of small molecules in gas, liquid, and headspace samples. The product line consists of three instrument tiers (spectraMRR flagship, isoMRR routine analyzer, and nanoMRR benchtop), SpectrAline preconcentration cartridges co-developed with Restek, and Edgar/BrightHub software for method development, automated spectral analysis, and library building.

Is BrightSpec a public or private company?

BrightSpec is a private company. It is classified as venture growth investor backed and is currently operating.

When was BrightSpec founded?

BrightSpec was founded in 2012. It employs 11 to 50 people.

Where is BrightSpec based?

BrightSpec is headquartered in Charlottesville, United States, in the North America region.

How does BrightSpec make money?

Two revenue lines are on record. MRR Instrumentation Sales are the primary driver. The others are software and Support Services.

Who are BrightSpec's main competitors?

Broad incumbents on record are Bruker Corporation, Agilent Technologies, Thermo Fisher Scientific, Waters Corporation, JEOL Ltd., Shimadzu Scientific Instruments and PerkinElmer. Emerging players are 908 Devices, MOBILion Systems and Advion.

Does BrightSpec have an API?

No public API is recorded for BrightSpec.

What industry is BrightSpec in?

BrightSpec's product category is Analytical Instrumentation (Life Science Tools). Its primary akta.pro industry code is HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments, with a secondary code of HLAGADAK, Material Characterization & Spectroscopy (NMR/FTIR/MS). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceBrightSpec and Restek Announce Launch of SpectrAline™ Cartridges, a High-Performance Sample Introduction Solution for Molecular Rotational Resonance (MRR)BrightSpec and Restek Corporation announced the launch of SpectrAline™ Cartridges, a preconcentration column product co-developed for Molecular Rotational Resonance (MRR) spectroscopy. The cartridges, manufactured by Restek under a multi-year supply agreement and delivered as a co-branded component by BrightSpec, are designed to enhance sensitivity, improve sample loading efficiency, and enable analysis of challenging sample matrices for MRR workflows. The product will be available for order beginning in June 2026.citybizBrightSpec Names Rick Gordon as CEOBrightSpec has appointed Rick Gordon as its new Chief Executive Officer, replacing the previous leadership. Mr. Gordon brings over 25 years of experience in the scientific tools industry, having previously scaled Halo Labs to its acquisition by Waters Corporation. He will lead the company's global commercialization efforts for its spectraMRR platform, which utilizes molecular rotational resonance spectroscopy.American City Business JournalsBrightSpec raises millions to commercialize its scientific instrumentBrightSpec Inc. closed an $18.4 million Series C round led by Genoa Ventures and Arboretum Ventures to commercialize its molecular rotational resonance spectrometer. The instrument, originally developed at the University of Virginia, will be sold for $250,000–$500,000, down from $1 million, and the company expects to grow from 15 to 30 employees.FinSMEsBrightSpec Raises $18.4M in Series C FinancingBrightSpec, a life science tools company based in Charlottesville, Virginia, raised $18.4 million in Series C funding led by Genoa Ventures and Arboretum Ventures. The company plans to utilize the capital to expand its development efforts and business reach for its MRR spectroscopic technology. This investment includes board seats for representatives from the lead investors to support strategic growth.PR NewswireBrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum VenturesBrightSpec, Inc. announced the closing of an $18.4 million Series C financing round led by Genoa Ventures and Arboretum Ventures, with participation from existing investors including Medvest Capital, Felton Group LLC, and the UVA Seed Fund. Representatives from the lead investors joined BrightSpec's Board of Directors to support the company's commercialization of its Molecular Rotational Resonance (MRR) spectroscopy technology for the pharmaceutical and industrial chemical sectors.Venture Capital Access OnlineBrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum VenturesBrightSpec, Inc. closed an $18.4 million Series C financing round led by Genoa Ventures and Arboretum Ventures, with participation from existing investors Medvest Capital, Felton Group LLC, and the UVA Seed Fund. Representatives from the lead investors joined BrightSpec's Board of Directors to support the commercialization of its Molecular Rotational Resonance (MRR) spectroscopy technology. The funding aims to advance the company's hardware and software solutions for chemical structural elucidation in pharmaceutical and industrial markets.PR NewswireBrightSpec, Inc. Announces the Appointment of Terry Dunlay to its Board of DirectorsBrightSpec, Inc. announced the appointment of R. Terry Dunlay to its Board of Directors, effective September 1, 2021, as part of the company's acceleration of commercialization efforts. Dunlay brings over 30 years of life science industry experience, having previously founded and led IntelliCyt Corporation, which was acquired by Sartorius AG in 2016, and co-founded Cellomics, which was acquired by Thermo Fisher in 2005. The company stated that Dunlay's track record of developing successful companies that were subsequently acquired will bring value to current and future investors as BrightSpec scales its MRR molecular analysis instruments.PR NewswireBASF Adopts BrightSpec's Broadband MRR Technology for Structural ElucidationBASF began operating a BrightSpec broadband Molecular Rotational Resonance spectrometer at its Ludwigshafen research center. The technology enables structure elucidation of organic compounds, including stereochemical analysis and gas-phase samples, without purification. BASF plans to develop routine applications for online process analytics and quality control.